首页 | 本学科首页   官方微博 | 高级检索  
     

紫杉醇联合顺铂治疗非小细胞肺癌45例临床研究
引用本文:李高峰. 紫杉醇联合顺铂治疗非小细胞肺癌45例临床研究[J]. 医疗保健器具, 2010, 17(9): 71-72. DOI: 10.3936/j.issn.1674-4659.2010.09.071
作者姓名:李高峰
作者单位:广西柳州市工人医院,肿瘤科,广西,柳州,545005
摘    要:
目的探讨紫杉醇+顺铂联合化疗方案对非小细胞肺的临床疗效和安全性。方法 45例患者给予紫杉醇75mg/m2i.v.d1+顺铂80mg/m2i.v.分三天用,每21天为一周期。结果入组的45例中,治疗后完全缓解(CR)3例,占6.70%,部分缓解(PR)24例,占53.33%,无变化(NC)15例,占33.33%,总有效率CR+PR为60.00%;不良反应主要有中性粒细胞减少、贫血、粒细胞减少性发热、其他发热、脱发、恶心呕吐和乏力。结论紫杉醇+顺铂联合化疗方案对非小细胞肺癌有一定疗效,且毒性可耐受。

关 键 词:非小细胞肺癌  紫杉醇  顺铂  化疗

Clinical Study of Taxel plus DDP in the Treatment of Non-small-cell Lung Cancer (NSCLC)
Li Gao-feng. Clinical Study of Taxel plus DDP in the Treatment of Non-small-cell Lung Cancer (NSCLC)[J]. Medicine Healthcare Apparatus, 2010, 17(9): 71-72. DOI: 10.3936/j.issn.1674-4659.2010.09.071
Authors:Li Gao-feng
Affiliation:Li Gao-feng(Department of oncology of Liu Worker's Hospital,Guang Xi,Liu Zhou China 545005)
Abstract:
Objective To investigate the effects and side effects of Taxel plus Cisplatin regimens in patients suffering from non-small-cell lung cancer(NSCLC).Methods 45 patients suffered from NSCLC treated by Taxel 75mg/m2 i.v.d 1 plus Cisplatin 80mg/m2 i.v.every 3 weeks.Results The effective rate(CR + PR) was 60.00%.The major toxicities were neutropenia,anemia,febrile neutropenia,fever,alopecia,nausea,vomiting and fatigue.Conclusion Taxel plus cisplatin regimens is an effective and well-tolerated treatment in patients suffering from NSCLC.
Keywords:Non-small-cell lung cancer(NSCLC)  Taxel  Cisplatin  Chemotherapy
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号